Cyberonics to Present at 22nd Annual Piper Jaffray Health Care Conference
HOUSTON, Nov. 17, 2010 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the 22nd Annual Piper Jaffray Health Care Conference in New York on Tuesday, November 30, 2010 at 1:30 PM ET. The conference session and webcast will be audio only and no formal slides will be presented. Piper Jaffray will host a webcast of the presentation live and by replay at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=CYBX&item_id=3494627. The conference webcast replay will be available for 90 days following the conference. The conference webcast can also be accessed at http://www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.
About Cyberonics, Inc. and VNS Therapy®
Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
Additional information on Cyberonics and VNS Therapy is available at www.cyberonics.com.
Contact Information |
|
Greg Browne, CFO |
|
Cyberonics, Inc. |
|
100 Cyberonics Blvd. |
|
Houston, TX 77058 |
|
Main: (281) 228-7262 |
|
Fax: (281) 218-9332 |
|
SOURCE Cyberonics, Inc.
Share this article